«Necrosis

Below is an extended Necrosis patents listing. Click here to return to the Necrosis main in depth entry.

Patents :
US Patent No.	Title
7427659	Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
7429265	System and method for moving and stretching plastic tissue
7429377	Therapeutic composition containing a plurality of immobilized proteases
7429378	Transdiscal administration of high affinity anti-MMP inhibitors
7429379	TNF receptor action modulation
7429380	Production of a multimeric protein by cell fusion method
7429381	Production and use of novel peptide-based agents for use with bi-specific antibodies
7429383	Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
7429384	Chimeric antagonist anth1
7429385	Intracellular production of hepatitis C E1 and E2 truncated polypeptides
7429450	HIP1 cancer markers
7429262	Apparatus and methods for electrosurgical ablation and resection of target tissue
7429260	Systems and methods for electrosurgical tissue contraction within the spine
7427702	Inbred corn line PHADP
7427664	Antibodies to polypeptides that stimulate TNF-.alpha. release
7427667	PRO9835 antibodies
7427668	Antibodies binding the TNF related protein, TNF-Y
7427669	ULBP antibodies
7427681	Pyrazole compounds useful as protein kinase inhibitors
7427685	Therapeutic substituted cyclopentanes
7427689	ErbB-2 selective small molecule kinase inhibitors
7427697	Sugar beet genes involved in stress tolerance
7427700	Inbred corn line PH907
7427701	Inbred corn line PHAJE
7429459	Methods for identifying a compound that inhibits the procession of amyloid-beta protein production in a mammalian cell expressing APP and overexpressing a G-protein coupled receptor in the cell
7429471	Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
7429643	POSH nucleic acids, polypeptides and related methods
7429644	Humanized anti-LT-.beta.-R antibodies
7429645	Humanized anti-lymphotoxin beta receptor antibodies
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7429648	IREN protein, its preparation and use
7429652	Compositions and methods for generating chimeric heteromultimers
7429681	Combretastatin analogs with tubulin binding activity
7429694	Celery cultivar ADS-12
7429695	Inbred corn line PHC5H
7429696	Plants and seeds of hybrid corn variety CH052066
7429641	PRO9830 polypeptides
7429640	PRO6181 polypeptides
7429611	Indole inhibitors of 15-lipoxygenase
7429481	Targeting viruses using a modified sindbis glycoprotein
7429488	Method for processing lipoaspirate cells
7429489	Methods of controlling proliferation and differentiation of stem and progenitor cells
7429559	Controlled release composition and method of producing the same
7429566	Method for treating Hemophilia B
7429569	Compositions and methods for the regulation of homocysteine levels within the body
7429570	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
7429594	Substituted heterocyclic compounds and methods of use
7429599	Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
7429609	Pyrazole compound and medicinal composition containing the same
7430476	Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.